S. K. Lane-Reticker

发表

Loss of ADAR1 in tumours overcomes resistance to immune checkpoint blockade

John G Doench, J. Doench, E. Levanon, 2018, Nature.

In vivo CRISPR screens reveal the landscape of immune evasion pathways across cancer

N. Hacohen, Dennie T. Frederick, D. Root, 2022, Nature Immunology.

Precocious Interleukin 21 Expression in Naive Mice Identifies a Natural Helper Cell Population in Autoimmune Disease.

G. Carter, Giljun Park, D. Roopenian, 2017, Cell reports.

In vivo screens using a selective CRISPR antigen removal lentiviral vector system reveal immune dependencies in renal cell carcinoma.

John G Doench, J. Doench, W. Haining, 2021, Immunity.

Protocol for in vivo CRISPR screening using selective CRISPR antigen removal lentiviral vectors

J. Doench, K. Yates, Emily A. Kessler, 2023, STAR protocols.

Loss of ADAR1 in tumours overcomes resistance to immune checkpoint blockade

J. Doench, E. Levanon, W. Haining, 2018, Nature.

Pooled in vivo screens for cancer immunotherapy target discovery.

W. Haining, Robert T. Manguso, S. K. Lane-Reticker, 2018, Immunotherapy.

In vivo CRISPR screens reveal the landscape of immune evasion pathways across cancer

John G Doench, N. Hacohen, Dennie T. Frederick, 2022, Nature Immunology.